Literature DB >> 11312637

Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down's syndrome.

N Massin1, J L Frendo, J Guibourdenche, D Luton, Y Giovangrandi, F Muller, M Vidaud, D Evain-Brion.   

Abstract

The syncytiotrophoblast (ST) is a major component of the human placenta as it is involved in feto-maternal exchanges and the secretion of pregnancy-specific hormones. We have studied the formation and function of the ST in normal and trisomy 21 (T21)-affected placenta using the in vitro model of cytotrophoblast differentiation into ST. Cytotrophoblast cells were isolated from first trimester, second trimester and term placentae. In vitro cytotrophoblast cells isolated from normal placenta fused to form the ST. This was associated with an increase in the transcript levels and the secretion of human chorionic gonadotropin (hCG). However, the secretion of hCG decreased through pregnancy. In T21-affected placentae, we observed a defect (or a delay) in ST formation and a dramatic decrease in the synthesis and secretion of this hormone compared with cultured cells isolated from control age-matched placentae. These results were confirmed by a significant (P < 0.05) decrease in transcript levels of alpha and beta subunits of hCG in total homogenates of T21-affected placentae compared with controls. These results suggest a decrease in functional mass of ST in T21 placenta, and therefore a decrease in production of placental pregnancy-specific polypeptide hormones. Copyright 2001 IFPA and Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312637     DOI: 10.1053/plac.2001.0658

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  7 in total

Review 1.  Placental growth hormones.

Authors:  Marie-Christine Lacroix; Jean Guibourdenche; Jean-Louis Frendo; Guillaume Pidoux; Danièle Evain-Brion
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Extragonadal actions of chorionic gonadotropin.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

3.  Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta.

Authors:  Jun Sugimoto; Danny J Schust; Tomomi Yamazaki; Yoshiki Kudo
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

4.  Fine-scale quantification of HCG beta gene transcription in human trophoblastic and non-malignant non-trophoblastic tissues.

Authors:  K Rull; P Hallast; L Uusküla; J Jackson; M Punab; A Salumets; R K Campbell; M Laan
Journal:  Mol Hum Reprod       Date:  2007-11-29       Impact factor: 4.025

Review 5.  Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology.

Authors:  Nicole Grandi; Enzo Tramontano
Journal:  Viruses       Date:  2017-06-27       Impact factor: 5.048

Review 6.  On Placental Toxicology Studies and Cerium Dioxide Nanoparticles.

Authors:  Gaëlle Deval; Sonja Boland; Thierry Fournier; Ioana Ferecatu
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

7.  Association between DSCR4 gene methylation in plasma in early pregnancy and Down's syndrome.

Authors:  Lingyu Hu; Changju Zhou
Journal:  Exp Ther Med       Date:  2018-01-16       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.